This assay is designed for the detection of anti-CCP3 IgG and IgA antibodies in patient sera, citrated or EDTA plasma. The presence of these antibodies can aid in the diagnosis of rheumatoid arthritis (RA), including RA diagnosed within 2 years of presentation of symptoms.

IVD-In Vitro Diagnostic Use / CE marked

Technology
ELISA

CLIA complexity
High

Package Size
10 X 96 wells

Disease Area Application
Rheumatoid Arthritis (RA)

Antigen Source
Synthetic peptide

Availability
Worldwide

Files & Resources


704550.10_Directional_Insert (English)

704550.10_Directional_Insert (English)

704550.10_Safety_Data_Sheet (English)

704550.10_Safety_Data_Sheet (English)

Certificate of Analysis

QUANTA Lite® CCP3.1 Brochure A4

QUANTA Lite® CCP3.1 Brochure US

Third generation anti-citrullinated peptide antibody assay

Contact us


Please contact us directly via email, telephone, or with the following form.

EMAIL:

support@inovadx.com

TOLL FREE PHONE:

800.545.9495

PHONE:

858.586.9900

FAX:

858.586.9911